TEVA FY 2017 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$36B

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$22.4B+2.2% YoY

Gross Profit

$10.8B48.4% margin

Operating Income

-$17.5B-78.1% margin

Net Income

-$16.3B-72.7% margin

EPS (Diluted)

$-16.01

Cash Flow

Operating Cash Flow

$3.5B

Free Cash Flow

$2.6B

Stock-Based Comp.

$133M

Balance Sheet

Total Assets

$70.6B

Total Liabilities

$51.9B

Stockholders' Equity

$17.4B

Cash & Equivalents

$963M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22.4B	$21.9B	+2.2%
Gross Profit	$10.8B	$11.9B	-8.7%
Operating Income	-$17.5B	$2.2B	-911.7%
Net Income	-$16.3B	$329M	-5043.8%